
April 4, 2025
Trump Administration Finalizes Pared Back MA And Part D Rule for 2026 The 2026 Medicare Advantage (MA) and Part D rule was finalized by the new Trump administration and it did not finalize many portions of the Biden administration proposed rule. These could be acted on after further review or never see the light of day again. Significant things not finalized: CMS did finalize several things and this is by no means a full list: The Final Notice for rates and other Star measures should be out Monday as well. CMS Fact Sheet: https://www.cms.gov/newsroom/fact-sheets/contract-year-2026-policy-and-technical-changes-medicare-advantage-program-medicare-prescription-final Additional articles: https://www.fiercehealthcare.com/payers/medicare-advantage-final-rule-excludes-anti-obesity-drug-coverage-under-medicare-medicaid and https://insidehealthpolicy.com/daily-news/trump-finalizes-prior-auth-hospital-stay-reqs-medicare-advantage-rule and https://insidehealthpolicy.com/daily-news/cms-declines-finalize-ma-ai-guardrails-expresses-interest-future-ai-regulation and https://thehill.com/homenews/5233357-medicare-medicaid-obesity-biden-trump/ and https://insidehealthpolicy.com/daily-news/cms-scraps-biden-plan-cover-anti-obesity-medications and https://www.modernhealthcare.com/policy/medicare-advantage-prior-authorization-ai (Some articles may require a subscription.) #medicareadvantage #partd #cms #regulations #star #quality #glp1s #priorauthorization https://www.modernhealthcare.com/politics-policy/medicare-obesity-drug-coverage-trump FTC Chair Reverses Recusal And PBM Suit Can Proceed Federal Trade Commission (FTC) Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency’s